Neuvana develops wearable neuromodulation devices designed to support stress reduction, sleep improvement, and cognitive focus through non-invasive stimulation. The company’s flagship product, Xen, is delivered in a headphone-style form factor intended for everyday use. Its approach focuses on engaging peripheral nerve pathways to influence autonomic regulation. Neuvana positions its technology within applied neuroscience and wellness contexts rather than clinical treatment.

The technology delivers transcutaneous vagus nerve stimulation using gentle electrical signals applied through the ear. By stimulating vagal afferents, the system aims to influence brain networks involved in relaxation, arousal, and stress response. Stimulation sessions are designed to be brief and user-controlled, supporting integration into daily routines. The platform does not involve neural recording, emphasizing simplicity and comfort over data collection.

Neuvana targets individuals seeking non-pharmacological tools for managing stress, improving sleep quality, and enhancing focus. The Xen system is positioned outside regulated medical pathways and is intended for consumer use. Its focus reflects growing interest in wearable, peripheral nerve stimulation devices as accessible tools for self-regulation and mental well-being.